AI
MRK icon

Accredited Investors’s Merck MRK Stock Holding History

Accredited Investors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
12,543
+1,602
+15% +$188K 0.07% 88
2026
Q1 		$1.32M Sell
10,941
-863
-7% -$99.6K 0.07% 90
2025
Q4 		$1.24M Buy
11,804
+1,946
+20% +$183K 0.07% 92
2025
Q3 		$827K Buy
9,858
+19
+0.2% +$1.56K 0.05% 111
2025
Q2 		$779K Sell
9,839
-972
-9% -$77.3K 0.05% 108
2025
Q1 		$970K Sell
10,811
-958
-8% -$89.4K 0.06% 93
2024
Q4 		$1.17M Sell
11,769
-65
-0.5% -$6.7K 0.07% 85
2024
Q3 		$1.34M Buy
11,834
+109
+0.9% +$12.9K 0.08% 80
2024
Q2 		$1.45M Sell
11,725
-1
-0% -$129 0.09% 72
2024
Q1 		$1.55M Buy
11,726
+271
+2% +$33.4K 0.1% 74
2023
Q4 		$1.25M Buy
11,455
+16
+0.1% +$1.66K 0.09% 78
2023
Q3 		$1.18M Buy
11,439
+50
+0.4% +$5.39K 0.09% 76
2023
Q2 		$1.31M Sell
11,389
-708
-6% -$80.4K 0.09% 71
2023
Q1 		$1.29M Sell
12,097
-248
-2% -$26.8K 0.1% 66
2022
Q4 		$1.37M Buy
12,345
+324
+3% +$33.1K 0.12% 59
2022
Q3 		$1.03M Buy
12,021
+627
+6% +$56K 0.12% 64
2022
Q2 		$1.04M Sell
11,394
-112
-1% -$9.93K 0.12% 69
2022
Q1 		$944K Buy
11,506
+82
+0.7% +$6.46K 0.09% 79
2021
Q4 		$876K Sell
11,424
-1,163
-9% -$92.6K 0.08% 83
2021
Q3 		$945K Buy
12,587
+7
+0.1% +$532 0.1% 75
2021
Q2 		$978K Sell
12,580
-643
-5% -$47.8K 0.1% 75
2021
Q1 		$973K Buy
13,223
+45
+0.3% +$3.32K 0.13% 72
2020
Q4 		$1.03M Buy
13,178
+267
+2% +$20.4K 0.17% 60
2020
Q3 		$1.02M Buy
12,911
+12
+0.1% +$940 0.21% 55
2020
Q2 		$952K Buy
12,899
+29
+0.2% +$2.18K 0.19% 54
2020
Q1 		$945K Sell
12,870
-99
-0.8% -$7.78K 0.22% 49
2019
Q4 		$1.13M Buy
12,969
+733
+6% +$60.2K 0.19% 49
2019
Q3 		$983K Sell
12,236
-315
-3% -$25.2K 0.19% 53
2019
Q2 		$1M Hold
12,551
– – 0.2% 56
2019
Q1 		$996K Buy
12,551
+26
+0.2% +$1.95K 0.2% 53
2018
Q4 		$913K Buy
12,525
+2,016
+19% +$142K 0.2% 46
2018
Q3 		$711K Sell
10,509
-30
-0.3% -$1.91K 0.18% 52
2018
Q2 		$610K Buy
10,539
+124
+1% +$7K 0.16% 53
2018
Q1 		$541K Buy
10,415
+316
+3% +$17.1K 0.15% 56
2017
Q4 		$542K Buy
10,099
+133
+1% +$7.37K 0.15% 58
2017
Q3 		$609K Buy
9,966
+1,189
+14% +$72.1K 0.17% 56
2017
Q2 		$537K Sell
8,777
-1,872
-18% -$114K 0.14% 48
2017
Q1 		$646K Buy
10,649
+219
+2% +$13.3K 0.16% 49
2016
Q4 		$586K Buy
10,430
+16
+0.2% +$936 0.15% 49
2016
Q3 		$620K Sell
10,414
-225
-2% -$13.2K 0.17% 45
2016
Q2 		$570K Buy
10,639
+1,076
+11% +$57.3K 0.16% 52
2016
Q1 		$483K Buy
9,563
+24
+0.3% +$1.18K 0.12% 58
2015
Q4 		$481K Buy
9,539
+23
+0.2% +$1.16K 0.12% 56
2015
Q3 		$449K Buy
9,516
+2,576
+37% +$137K 0.12% 51
2015
Q2 		$378K Buy
6,940
+315
+5% +$17.7K 0.1% 49
2015
Q1 		$364K Hold
6,625
– – 0.09% 49
2014
Q4 		$360K Sell
6,625
-35
-0.5% -$1.95K 0.11% 46
2014
Q3 		$375K Buy
6,660
+35
+0.5% +$1.97K 0.11% 47
2014
Q2 		$366K Hold
6,625
– – 0.12% 44
2014
Q1 		$359K Buy
6,625
+2,307
+53% +$119K 0.12% 43
2013
Q4 		$207K Sell
4,318
-1,005
-19% -$45.9K 0.07% 54
2013
Q3 		$242K Sell
5,323
-221
-4% -$10.1K 0.09% 48
2013
Q2 		$246K Buy
+5,544
New +$248K 0.1% 49

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Accredited Investors's MRK Position: Q2 2026 in Review

Accredited Investors increased its Merck (MRK) stake by 15% in Q2 2026, buying an estimated $188K and bringing the position to 12,543 shares worth $1.61M. The position accounts for 0.07% of the portfolio, ranked #88.

Accredited Investors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Accredited Investors held 12,543 shares of Merck worth $1.61M as of Q2 2026.
  • Accredited Investors bought 1,602 Merck shares in Q2 2026, an estimated $188K.
  • Merck made up 0.07% of Accredited Investors's portfolio in Q2 2026, its #88 holding.
  • Accredited Investors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.